Qlife Holding AB (publ)
QLIFE.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$17.34M
Close$
$-1.16
195.1% downside
Current Fair Value
195.1% downsideOvervalued by 195.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $17.34 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.64 |
| Beta | 0.6 |
| Outstanding Shares | 20,924,499 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.74 |
|---|---|
| PEG | 19.58 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$-283.87
Average shareholder expectationRevenue Estimate
$1.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-283.87
Average shareholder expectationRevenue Estimate
$1.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Qlife Holding AB (publ)
2 employees
CEO: Thomas Warthoe Operating as a medical technology firm, Qlife Holding AB (publ) specializes in the production and distribution of in-vitro diagnostic instruments and their associated chemical reagents. Their flagship offering is the Egoo.Health Platform...